Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Compensation Mechanisms01:28

Compensation Mechanisms

463
The human body employs intricate mechanisms to counteract changes in blood pH, preventing conditions like acidosis (pH < 7.35) and alkalosis (pH > 7.45). These compensatory responses aim to restore normal arterial blood pH by engaging respiratory or renal systems, depending on the source of the imbalance.
Respiratory Compensation
This mechanism addresses metabolic-induced pH imbalances by adjusting breathing rates. Respiratory compensation begins within minutes of detecting a pH...
463
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

883
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
883
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

1.0K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

151
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
151
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.7K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

593
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
593

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paradox of engagement: precautionary public health alerts and gender inequality in cancer diagnosis-a quasi-experimental study.

BMJ quality & safety·2026
Same author

Patient Perspectives on and Willingness to Pay for Navigation Services Billed Under Centers for Medicare & Medicaid Services Principal Illness Navigation Codes.

JCO oncology practice·2026
Same author

Sociodemographic Paradoxes and Enrollment Differences in In-Person Versus Online Recruitment to a Mobile Health Smoking Cessation Intervention for Food-Insecure Adults: Secondary Analysis of a Randomized Controlled Trial.

Journal of medical Internet research·2026
Same author

Colorectal cancer screening: An update to the American Cancer Society guideline, 2026.

CA: a cancer journal for clinicians·2026
Same author

Identifying Meaningful Patient Savings on Generics: Direct-to-Consumer Prices Versus Commercial Insurance Cost Sharing.

Annals of internal medicine·2026
Same author

The arrival of digital twins and in silico trials in drug development.

Nature medicine·2026

Related Experiment Video

Updated: Aug 1, 2025

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

965

Incorporating Cost Measures Into the Merit-Based Incentive Payment System: Implications for Oncologists.

Vishal R Patel1, Thomas B Cwalina2, Nico Nortj3

  • 1Dell Medical School, The University of Texas at Austin, Austin, TX.

JCO Oncology Practice
|April 24, 2023
PubMed
Summary
This summary is machine-generated.

Oncologists face disproportionately higher penalties under the Merit-Based Incentive Payment System (MIPS) due to specialty-agnostic cost measures. This study highlights the need for MIPS cost measure recalibration to ensure fair value-based care policies.

More Related Videos

Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
04:45

Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way

Published on: May 10, 2021

3.8K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

Related Experiment Videos

Last Updated: Aug 1, 2025

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

965
Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
04:45

Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way

Published on: May 10, 2021

3.8K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

Area of Science:

  • Health Policy
  • Health Economics
  • Oncology

Background:

  • The Merit-Based Incentive Payment System (MIPS) is the primary federal value-based payment model for physicians in the United States.
  • MIPS has progressively increased the weight of cost measures, rising from 0% in 2017 to 30% in 2022.
  • Specialty-agnostic cost measures may disproportionately impact high-cost specialties like oncology.

Purpose of the Study:

  • To investigate the impact of MIPS cost measure integration on physician reimbursement.
  • To analyze the financial implications for oncologists compared to other medical specialties.

Main Methods:

  • Evaluation of physician performance data from the 2018 MIPS using the Doctors and Clinicians database.
  • Application of multivariable Tobit regression to identify factors associated with cost and quality scores.
  • Simulation of 2022 MIPS composite scores and payment adjustments using 2018 data to compare cross-specialty changes.

Main Results:

  • Oncologists represented 3.5% of MIPS-participating physicians and exhibited lower cost scores (58.4) than non-oncologists (71.0).
  • After applying 2022 cost-quality weights, oncologists experienced a 4.3-point reduction in composite MIPS scores.
  • Oncologists faced a four-fold increase in penalty magnitude (from $4,233.41 to $18,531.06) and a greater reduction in exceptional payment bonuses compared to other specialties.

Conclusions:

  • Oncologists are likely to be disproportionately penalized by the current MIPS cost measure structure.
  • Specialty-specific recalibration of MIPS cost measures is essential.
  • Policy adjustments are needed to prevent value-based care initiatives from negatively impacting healthcare quality and patient outcomes.